Current solar PV module price increases are largely dictated by five major components, according to data from Intertek CEA.

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

Cullinan Therapeutics (NASDAQ:CGEM) outlined a milestone-heavy roadmap during a presentation at Leerink Partners’ Annual ...

QuantumScape is on a mission to significantly improve battery technology, but it still has its work cut out for it.

Silicon Valley is pulling the plug. The Kremlin is locking the doors. Inside the race to cut Russia off from the global ...

From anti-ageing claims to “cellular regeneration” and faster gym recovery, hyperbaric oxygen chambers have become a luxury ...

After her initial test run, she cultured a regular sample, as well as the shocked sample so she could compare them side by ...

Discover latest PTA telecom consumer complaints data for Jan 2026. Jazz leads the chart, followed by Zong. See the full operator breakdown.

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best get-rich-quick stocks to buy according to hedge funds. On February 24, Iovance Biotherapeutics announced positive early data from a pilot ...

An Informational Consumer Analysis of AgelessRx's Prescription Process, NAD+ Therapies, GLP-1 and Compounded Semaglutide Options, Off-Label Longevity Medications, and Cash-Pay Pricing Structure for 20 ...

Learn more about whether Revvity, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A tech entrepreneur has created a personalised cancer vaccine for his dog, a breakthrough experts say could shape the future ...